Global E-Health Forum: Designing Personalized Healthcare

11 - 13 October 2011, Hamburg, Germany.
Dr. Eric M. Liederman (Director of Medical Informatics, The Permanente Medical Group, U.S.A.) has confirmed his keynote at this year's Global E-Health Forum. He will present "Balancing Privacy Protection with Patient Care".

Healthcare organizations are under increasing regulatory pressure to improve the quality and safety of care and to protect patient privacy. Electronic Health Records (EHR) provide a vehicle to improve care, however concerns over protecting the system against privacy violations are a significant challenge. Dr. Eric Liederman will discuss how to achieve a balance between protecting privacy and security, and fostering high quality patient care.

Learn how Kaiser Permanente's "trust, but hold accountable" approach using forensic mining of its EHR audit databases, resulted in a > 90% reduction in privacy violations over several weeks. Learn how deterrence methods have also helped clinicians and staff avoid giving in to career-ending temptation.

Canada is Partner Country
Mr. Peter M. Boehm, Ambassador of Canada in Germany is pleased to endorse the Global E-Health Forum in Hamburg. He states: "Developing successful e-health solutions requires combining knowledge and technology in several key areas, including: enabling electronic communications infrastructure; providing remote communities in Canada with access to clinical and non-clinical healthcare professionals through the use of advanced information communications technologies; improving health information systems to support service delivery including virtual health libraries; and upholding the health privacy of patients through high standards of information management and exchange." For full text, please see http://www.global-ehealth-forum.com/canada/.

Transforming healthcare in Canada through e-health, the challenges facing the health system in Canada and the role of information and information technology within a reformed health system - these are the topics Richard C. Alvarez, President and Chief Executive Officer, Canada Health Infoway, will address in his keynote.

Program
The first two conference days at the Hamburg Chamber of Commerce will feature more speakers from all over the globe. Their strategy presentations and case studies will be complemented by discussion forums, workshops and an exhibition of solution providers. The official reception for the conference delegates will take place in the U.S. Consulate General ("the little White House at the lake Alster") on October 11. The third day is dedicated to various breakout sessions and guided tours at different locations (among others hospitals) targeting the individual information needs of special interest groups.

Registration
Register by August 30 for a conference fee of Euro 599 incl. VAT. The fee includes the admission to all conference sessions, lunches, coffee breaks and the evening reception on October 11, 2011.

For further information, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

New strategy to treat Parkinson's disease

Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harmful ge...

AI could offer warnings about serious side effects…

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ dama...

OPKO and Pfizer announce positive Phase 3 top-line…

OPKO Health Inc. (NASDAQ: OPK) and Pfizer Inc. (NYSE: PFE) announced that the global Phase 3 trial evaluating somatrogon dosed once-weekly in pre-pubertal children with g...

Trastuzumab deruxtecan granted FDA Priority Review…

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics Lice...

The Bristol-Myers Squibb-Pfizer Alliance and Fitbi…

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of a...

Nplate® (romiplostim) now approved for earlier use…

Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (sBLA) for Nplate® (romiplostim...

Bayer launches LifeHub UK focused on artificial in…

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The...

Novartis announces that Jakavi® (ruxolitinib) meet…

Novartis today announced positive topline results from the Phase III REACH2 study evaluating Jakavi® (ruxolitinib) in patients with steroid-refractory acute graft-versus-...

Amgen recommends rejection of 'mini-tender' offer …

Amgen (NASDAQ:AMGN) today announced that it has been notified of an unsolicited "mini-tender" offer dated Oct. 11, 2019, made by TRC Capital Corporation, a private Canadi...

Antibody-based eye drops show promise for treating…

Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodi...

First entirely digital clinical trial encourages p…

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new s...

Abbott and Omada Health partner to offer integrate…

Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) ...